Finn, Richard S.; Qin, Shukui; Ikeda, Masafumi et al.
IMbrave150: updated efficacy and safety by risk status in patients (pts) receiving atezolizumab (atezo) plus bevacizumab (bev) vs sorafenib (sor) as first-line treatment for unresectable hepatocellular carcinoma (HCC)SWISS MEDICAL WEEKLY. Bd. 151. 2021 S. 25-26
Finn, Richard S.; Qin, Shukui; Ikeda, Masafumi et al.
IMbrave150: Updated efficacy and safety by risk status in patients (pts) receiving atezolizumab (atezo) plus bevacizumab (bev) vs sorafenib (sor) as first-line treatment for unresectable hepatocellular carcinoma (HCC).CANCER RESEARCH. Bd. 81. H. 13. 2021
Finn, Richard S.; Qin Shukui, ?; Ikeda, Masafumi et al.
IMbrave150: Updated overall survival (OS) data from a global, randomized, open-label phase III study of atezolizumab (atezo) plus bevacizumab (bev) versus sorafenib (sor) in patients (pts) with unresectable hepatocellular carcinoma (HCC).JOURNAL OF CLINICAL ONCOLOGY. Bd. 39. H. 3. 2021
Galle, P.; Finn, R. S.; Qin, S. et al.
IMbrave150: updated overall survival (OS) data from a global, randomized, open-label Phase III study of atezolizumab (atezo) plus bevacizumab (bev) vs sorafenib (sor) in patients (pts) with unresectable hepatocellular carcinoma (HCC)ONCOLOGY RESEARCH AND TREATMENT. Bd. 44. 2021 S. 34-34
Boedecker, Simone C.; Luessi, Felix; Engel, Sinah et al.
Immunoadsorption and plasma exchange-Efficient treatment options for neurological autoimmune diseasesJOURNAL OF CLINICAL APHERESIS. Bd. 37. H. 1. 2021 S. 70-81
Mueller, Lukas; Hahn, Felix; Maehringer-Kunz, Aline et al.
Immunonutritive Scoring for Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization: Evaluation of the CALLY IndexCANCERS. Bd. 13. H. 19. 2021
Mueller, Lukas; Hahn, Felix; Maehringer-Kunz, Aline et al.
Immunonutritive Scoring in Patients With Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization: Prognostic Nutritional Index or Controlling Nutritional Status Score?FRONTIERS IN ONCOLOGY. Bd. 11. 2021
Schmitt, Volker H.; Hobohm, Lukas; Wenzel, Philip et al.
Impact of diabetes mellitus on mortality rate and outcome in pulmonary embolismINTERNIST. Bd. 62. H. SUPPL 2. 2021 S. 174-174
Labenz, Christian; Kostev, Karel; Armandi, Angelo et al.
Impact of thyroid disorders on the incidence of non-alcoholic fatty liver disease in GermanyUNITED EUROPEAN GASTROENTEROLOGY JOURNAL. Bd. 9. H. 7. 2021 S. 829-836
Ugradar, Shoaib; Wang, Yao; Mester, Tunde et al.
Improvement of asymmetric thyroid eye disease with teprotumumabBRITISH JOURNAL OF OPHTHALMOLOGY. Bd. 106. H. 6. 2021 S. 755-759